$NBIX Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in NEUROCRINE BIOSCIENCES INC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of all insider trading transactions in NEUROCRINE BIOSCIENCES INC. Get notifications about new insider transactions in NEUROCRINE BIOSCIENCES INC for free.

Page:   1 2 3 4 5 ... 13 next >

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 20 2021NBIXNEUROCRINE BIOSCIE ...Sharp ShaliniDirectorOption ExerciseA92.358,833815,7288,833
May 20 2021NBIXNEUROCRINE BIOSCIE ...POPS RICHARD FDirectorOption ExerciseA92.358,833815,7288,833
Apr 16 2021NBIXNEUROCRINE BIOSCIE ...Mercier JohannaDirectorOption ExerciseA95.0017,1801,632,10017,180
Feb 12 2021NBIXNEUROCRINE BIOSCIE ...Lloyd-Smith MalcolmChief Regulatory Of ...Option ExerciseM35.991,70061,18321,533
Feb 12 2021NBIXNEUROCRINE BIOSCIE ...Lloyd-Smith MalcolmChief Regulatory Of ...SellS119.9560071,97332,51033.1 K to 32.5 K (-1.81 %)
Feb 12 2021NBIXNEUROCRINE BIOSCIE ...Lloyd-Smith MalcolmChief Regulatory Of ...BuyM35.9960021,59433,11032.5 K to 33.1 K (+1.85 %)
Feb 12 2021NBIXNEUROCRINE BIOSCIE ...Lloyd-Smith MalcolmChief Regulatory Of ...SellS119.961,100131,95332,51033.6 K to 32.5 K (-3.27 %)
Feb 12 2021NBIXNEUROCRINE BIOSCIE ...Lloyd-Smith MalcolmChief Regulatory Of ...BuyM35.991,10039,58933,61032.5 K to 33.6 K (+3.38 %)
Feb 09 2021NBIXNEUROCRINE BIOSCIE ...Cooke JulieChief Human Resourc ...Option ExerciseA0.005,31405,314
Feb 09 2021NBIXNEUROCRINE BIOSCIE ...Cooke JulieChief Human Resourc ...Option ExerciseA117.6331,8803,750,04431,880
Feb 09 2021NBIXNEUROCRINE BIOSCIE ...Cooke JulieChief Human Resourc ...SellS116.72913106,56613,73714.7 K to 13.7 K (-6.23 %)
Feb 09 2021NBIXNEUROCRINE BIOSCIE ...Cooke JulieChief Human Resourc ...SellS116.7642549,62312,91513.3 K to 12.9 K (-3.19 %)
Feb 09 2021NBIXNEUROCRINE BIOSCIE ...Cooke JulieChief Human Resourc ...SellS113.8660568,88612,12512.7 K to 12.1 K (-4.75 %)
Feb 09 2021NBIXNEUROCRINE BIOSCIE ...ROBERTS EIRYChief Medical Offic ...Option ExerciseA0.007,43907,439
Feb 09 2021NBIXNEUROCRINE BIOSCIE ...ROBERTS EIRYChief Medical Offic ...Option ExerciseA117.6344,6325,250,06244,632
Feb 09 2021NBIXNEUROCRINE BIOSCIE ...ROBERTS EIRYChief Medical Offic ...SellS116.831,623189,60718,69320.3 K to 18.7 K (-7.99 %)
Feb 09 2021NBIXNEUROCRINE BIOSCIE ...ROBERTS EIRYChief Medical Offic ...SellS116.6774086,33717,23118 K to 17.2 K (-4.12 %)
Feb 09 2021NBIXNEUROCRINE BIOSCIE ...Lloyd-Smith MalcolmChief Regulatory Of ...Option ExerciseA0.005,31405,314
Feb 09 2021NBIXNEUROCRINE BIOSCIE ...Lloyd-Smith MalcolmChief Regulatory Of ...Option ExerciseA117.6331,8803,750,04431,880
Feb 09 2021NBIXNEUROCRINE BIOSCIE ...Lloyd-Smith MalcolmChief Regulatory Of ...SellS116.871,015118,62432,51033.5 K to 32.5 K (-3.03 %)
Feb 09 2021NBIXNEUROCRINE BIOSCIE ...Lloyd-Smith MalcolmChief Regulatory Of ...SellS116.741,490173,93631,59733.1 K to 31.6 K (-4.50 %)
Feb 09 2021NBIXNEUROCRINE BIOSCIE ...Lloyd-Smith MalcolmChief Regulatory Of ...SellS116.8975688,36930,43731.2 K to 30.4 K (-2.42 %)
Feb 09 2021NBIXNEUROCRINE BIOSCIE ...Lloyd-Smith MalcolmChief Regulatory Of ...SellS114.1586598,73929,67530.5 K to 29.7 K (-2.83 %)
Feb 09 2021NBIXNEUROCRINE BIOSCIE ...Grigoriadis Dimitri E.Chief Research Offi ...Option ExerciseA0.006,37606,376
Feb 09 2021NBIXNEUROCRINE BIOSCIE ...Grigoriadis Dimitri E.Chief Research Offi ...Option ExerciseA117.6338,2564,500,05338,256
Feb 09 2021NBIXNEUROCRINE BIOSCIE ...Grigoriadis Dimitri E.Chief Research Offi ...SellS116.701,218142,14285,27386.5 K to 85.3 K (-1.41 %)
Feb 09 2021NBIXNEUROCRINE BIOSCIE ...Grigoriadis Dimitri E.Chief Research Offi ...SellS116.6980393,70584,17885 K to 84.2 K (-0.94 %)
Feb 09 2021NBIXNEUROCRINE BIOSCIE ...Grigoriadis Dimitri E.Chief Research Offi ...SellS116.6768780,15283,45684.1 K to 83.5 K (-0.82 %)
Feb 09 2021NBIXNEUROCRINE BIOSCIE ...Grigoriadis Dimitri E.Chief Research Offi ...SellS113.7660568,82382,16982.8 K to 82.2 K (-0.73 %)
Feb 09 2021NBIXNEUROCRINE BIOSCIE ...GORMAN KEVIN CHARLESChief Executive Off ...Option ExerciseA0.0017,269017,269
Feb 09 2021NBIXNEUROCRINE BIOSCIE ...GORMAN KEVIN CHARLESChief Executive Off ...Option ExerciseA117.63103,60912,187,527103,609
Feb 09 2021NBIXNEUROCRINE BIOSCIE ...GORMAN KEVIN CHARLESChief Executive Off ...SellS116.723,248379,089452,972456.2 K to 453 K (-0.71 %)
Feb 09 2021NBIXNEUROCRINE BIOSCIE ...GORMAN KEVIN CHARLESChief Executive Off ...SellS116.744,343506,999450,051454.4 K to 450.1 K (-0.96 %)
Feb 09 2021NBIXNEUROCRINE BIOSCIE ...GORMAN KEVIN CHARLESChief Executive Off ...SellS116.792,875335,775446,144449 K to 446.1 K (-0.64 %)
Feb 09 2021NBIXNEUROCRINE BIOSCIE ...GORMAN KEVIN CHARLESChief Executive Off ...SellS114.162,422276,504443,249445.7 K to 443.2 K (-0.54 %)
Feb 09 2021NBIXNEUROCRINE BIOSCIE ...Lippoldt DarinChief Legal OfficerOption ExerciseM35.9936,1941,302,6220
Feb 09 2021NBIXNEUROCRINE BIOSCIE ...Lippoldt DarinChief Legal OfficerOption ExerciseA0.006,90806,908
Feb 09 2021NBIXNEUROCRINE BIOSCIE ...Lippoldt DarinChief Legal OfficerOption ExerciseA117.6341,4444,875,05841,444
Feb 09 2021NBIXNEUROCRINE BIOSCIE ...Lippoldt DarinChief Legal OfficerSellS116.216,008698,16034,36140.4 K to 34.4 K (-14.88 %)
Feb 09 2021NBIXNEUROCRINE BIOSCIE ...Lippoldt DarinChief Legal OfficerBuyM35.996,008216,22840,36934.4 K to 40.4 K (+17.48 %)
Feb 09 2021NBIXNEUROCRINE BIOSCIE ...Lippoldt DarinChief Legal OfficerSellS117.5518621,86434,36134.5 K to 34.4 K (-0.54 %)
Feb 09 2021NBIXNEUROCRINE BIOSCIE ...Lippoldt DarinChief Legal OfficerBuyM35.991866,69434,54734.4 K to 34.5 K (+0.54 %)
Feb 09 2021NBIXNEUROCRINE BIOSCIE ...Lippoldt DarinChief Legal OfficerSellS116.1630,0003,484,80634,36164.4 K to 34.4 K (-46.61 %)
Feb 09 2021NBIXNEUROCRINE BIOSCIE ...Lippoldt DarinChief Legal OfficerBuyM35.9930,0001,079,70064,36134.4 K to 64.4 K (+87.31 %)
Feb 09 2021NBIXNEUROCRINE BIOSCIE ...Lippoldt DarinChief Legal OfficerSellS116.721,522177,65034,36135.9 K to 34.4 K (-4.24 %)
Feb 09 2021NBIXNEUROCRINE BIOSCIE ...Lippoldt DarinChief Legal OfficerSellS116.741,198139,85932,99134.2 K to 33 K (-3.50 %)
Feb 09 2021NBIXNEUROCRINE BIOSCIE ...Lippoldt DarinChief Legal OfficerSellS116.6968780,16631,91432.6 K to 31.9 K (-2.11 %)
Feb 09 2021NBIXNEUROCRINE BIOSCIE ...Lippoldt DarinChief Legal OfficerSellS114.0560569,00330,62731.2 K to 30.6 K (-1.94 %)
Feb 09 2021NBIXNEUROCRINE BIOSCIE ...Gano KyleChief Business Deve ...Option ExerciseA0.007,43907,439
Feb 09 2021NBIXNEUROCRINE BIOSCIE ...Gano KyleChief Business Deve ...Option ExerciseA117.6344,6325,250,06244,632
Feb 09 2021NBIXNEUROCRINE BIOSCIE ...Gano KyleChief Business Deve ...SellS116.831,623189,622104,768106.4 K to 104.8 K (-1.53 %)
Feb 09 2021NBIXNEUROCRINE BIOSCIE ...Gano KyleChief Business Deve ...SellS116.831,000116,826103,306104.3 K to 103.3 K (-0.96 %)
Feb 09 2021NBIXNEUROCRINE BIOSCIE ...Gano KyleChief Business Deve ...SellS116.891,070125,070102,406103.5 K to 102.4 K (-1.03 %)
Feb 09 2021NBIXNEUROCRINE BIOSCIE ...Gano KyleChief Business Deve ...SellS114.091,974225,207100,439102.4 K to 100.4 K (-1.93 %)
Feb 09 2021NBIXNEUROCRINE BIOSCIE ...Gano KyleChief Business Deve ...SellS113.7770379,97798,66399.4 K to 98.7 K (-0.71 %)
Feb 09 2021NBIXNEUROCRINE BIOSCIE ...ABERNETHY MATTChief Financial Off ...Option ExerciseA0.007,43907,439
Feb 09 2021NBIXNEUROCRINE BIOSCIE ...ABERNETHY MATTChief Financial Off ...Option ExerciseA117.6344,6325,250,06244,632
Feb 09 2021NBIXNEUROCRINE BIOSCIE ...ABERNETHY MATTChief Financial Off ...SellS116.812,030237,11614,86916.9 K to 14.9 K (-12.01 %)
Feb 09 2021NBIXNEUROCRINE BIOSCIE ...ABERNETHY MATTChief Financial Off ...SellS116.85880102,82613,04313.9 K to 13 K (-6.32 %)
Feb 09 2021NBIXNEUROCRINE BIOSCIE ...Bozigian Haig P.Chief Development O ...Option ExerciseA0.005320532
Feb 09 2021NBIXNEUROCRINE BIOSCIE ...Bozigian Haig P.Chief Development O ...Option ExerciseA117.633,188375,0043,188
Feb 09 2021NBIXNEUROCRINE BIOSCIE ...Bozigian Haig P.Chief Development O ...SellS116.791,623189,550157,651159.3 K to 157.7 K (-1.02 %)
Feb 09 2021NBIXNEUROCRINE BIOSCIE ...Bozigian Haig P.Chief Development O ...SellS116.781,395162,912156,189157.6 K to 156.2 K (-0.89 %)
Feb 09 2021NBIXNEUROCRINE BIOSCIE ...Bozigian Haig P.Chief Development O ...SellS116.8582496,286154,934155.8 K to 154.9 K (-0.53 %)
Feb 09 2021NBIXNEUROCRINE BIOSCIE ...Bozigian Haig P.Chief Development O ...SellS113.7970480,109153,328154 K to 153.3 K (-0.46 %)
Feb 09 2021NBIXNEUROCRINE BIOSCIE ...BENEVICH ERICChief Commercial Of ...Option ExerciseA0.007,43907,439
Feb 09 2021NBIXNEUROCRINE BIOSCIE ...BENEVICH ERICChief Commercial Of ...Option ExerciseA117.6344,6325,250,06244,632
Feb 09 2021NBIXNEUROCRINE BIOSCIE ...BENEVICH ERICChief Commercial Of ...SellS116.842,030237,18621,09923.1 K to 21.1 K (-8.78 %)
Feb 09 2021NBIXNEUROCRINE BIOSCIE ...BENEVICH ERICChief Commercial Of ...SellS116.761,395162,88019,27320.7 K to 19.3 K (-6.75 %)
Feb 09 2021NBIXNEUROCRINE BIOSCIE ...BENEVICH ERICChief Commercial Of ...SellS116.8984598,77518,01818.9 K to 18 K (-4.48 %)
Feb 09 2021NBIXNEUROCRINE BIOSCIE ...BENEVICH ERICChief Commercial Of ...SellS114.0380992,24716,43417.2 K to 16.4 K (-4.69 %)
Jan 27 2021NBIXNEUROCRINE BIOSCIE ...BENEVICH ERICChief Commercial Of ...Option ExerciseM41.7830012,53456,223
Jan 27 2021NBIXNEUROCRINE BIOSCIE ...BENEVICH ERICChief Commercial Of ...Option ExerciseM41.783,477145,26956,523
Jan 27 2021NBIXNEUROCRINE BIOSCIE ...BENEVICH ERICChief Commercial Of ...SellS120.0010012,00015,70515.8 K to 15.7 K (-0.63 %)
Jan 27 2021NBIXNEUROCRINE BIOSCIE ...BENEVICH ERICChief Commercial Of ...SellS120.0030036,00015,80516.1 K to 15.8 K (-1.86 %)
Jan 27 2021NBIXNEUROCRINE BIOSCIE ...BENEVICH ERICChief Commercial Of ...BuyM41.7830012,53416,10515.8 K to 16.1 K (+1.90 %)
Jan 27 2021NBIXNEUROCRINE BIOSCIE ...BENEVICH ERICChief Commercial Of ...SellS120.031,600192,04415,80517.4 K to 15.8 K (-9.19 %)
Jan 27 2021NBIXNEUROCRINE BIOSCIE ...BENEVICH ERICChief Commercial Of ...SellS120.033,477417,32717,40520.9 K to 17.4 K (-16.65 %)
Jan 27 2021NBIXNEUROCRINE BIOSCIE ...BENEVICH ERICChief Commercial Of ...BuyM41.783,477145,26920,88217.4 K to 20.9 K (+19.98 %)
Jan 27 2021NBIXNEUROCRINE BIOSCIE ...LYONS GARY ADirectorSellS120.0040048,000223,697224.1 K to 223.7 K (-0.18 %)
Jan 27 2021NBIXNEUROCRINE BIOSCIE ...LYONS GARY ADirectorSellS120.031,600192,047224,097225.7 K to 224.1 K (-0.71 %)
Jan 27 2021NBIXNEUROCRINE BIOSCIE ...Lloyd-Smith MalcolmChief Regulatory Of ...Option ExerciseM35.991,10039,58923,233
Jan 27 2021NBIXNEUROCRINE BIOSCIE ...Lloyd-Smith MalcolmChief Regulatory Of ...Option ExerciseM32.998,958295,5240
Jan 27 2021NBIXNEUROCRINE BIOSCIE ...Lloyd-Smith MalcolmChief Regulatory Of ...Option ExerciseM35.998,612309,94624,333
Jan 27 2021NBIXNEUROCRINE BIOSCIE ...Lloyd-Smith MalcolmChief Regulatory Of ...SellS119.9860071,98529,00229.6 K to 29 K (-2.03 %)
Jan 27 2021NBIXNEUROCRINE BIOSCIE ...Lloyd-Smith MalcolmChief Regulatory Of ...BuyM35.9960021,59429,60229 K to 29.6 K (+2.07 %)
Jan 27 2021NBIXNEUROCRINE BIOSCIE ...Lloyd-Smith MalcolmChief Regulatory Of ...SellS119.9650059,98029,00229.5 K to 29 K (-1.69 %)
Jan 27 2021NBIXNEUROCRINE BIOSCIE ...Lloyd-Smith MalcolmChief Regulatory Of ...BuyM35.9950017,99529,50229 K to 29.5 K (+1.72 %)
Jan 27 2021NBIXNEUROCRINE BIOSCIE ...Lloyd-Smith MalcolmChief Regulatory Of ...SellS119.958,9581,074,51229,00238 K to 29 K (-23.60 %)
Jan 27 2021NBIXNEUROCRINE BIOSCIE ...Lloyd-Smith MalcolmChief Regulatory Of ...BuyM32.998,958295,52437,96029 K to 38 K (+30.89 %)
Jan 27 2021NBIXNEUROCRINE BIOSCIE ...Lloyd-Smith MalcolmChief Regulatory Of ...SellS119.984,601552,04129,00233.6 K to 29 K (-13.69 %)
Jan 27 2021NBIXNEUROCRINE BIOSCIE ...Lloyd-Smith MalcolmChief Regulatory Of ...BuyM35.994,601165,59033,60329 K to 33.6 K (+15.86 %)
Jan 27 2021NBIXNEUROCRINE BIOSCIE ...Lloyd-Smith MalcolmChief Regulatory Of ...SellS119.994,011481,25929,00233 K to 29 K (-12.15 %)
Jan 27 2021NBIXNEUROCRINE BIOSCIE ...Lloyd-Smith MalcolmChief Regulatory Of ...BuyM35.994,011144,35633,01329 K to 33 K (+13.83 %)
Jan 12 2021NBIXNEUROCRINE BIOSCIE ...ROBERTS EIRYChief Medical Offic ...SellS111.062,632292,29715,84518.5 K to 15.8 K (-14.24 %)
Jan 12 2021NBIXNEUROCRINE BIOSCIE ...GORMAN KEVIN CHARLESChief Executive Off ...Option ExerciseM8.65164,8011,425,5290
Jan 12 2021NBIXNEUROCRINE BIOSCIE ...GORMAN KEVIN CHARLESChief Executive Off ...Option ExerciseM8.66143,4491,242,2680
Jan 12 2021NBIXNEUROCRINE BIOSCIE ...GORMAN KEVIN CHARLESChief Executive Off ...SellS110.22164,80118,164,778441,071605.9 K to 441.1 K (-27.20 %)
Jan 12 2021NBIXNEUROCRINE BIOSCIE ...GORMAN KEVIN CHARLESChief Executive Off ...BuyM8.65164,8011,425,529605,872441.1 K to 605.9 K (+37.36 %)
Jan 12 2021NBIXNEUROCRINE BIOSCIE ...GORMAN KEVIN CHARLESChief Executive Off ...SellS110.21143,44915,809,098441,071584.5 K to 441.1 K (-24.54 %)
Jan 12 2021NBIXNEUROCRINE BIOSCIE ...GORMAN KEVIN CHARLESChief Executive Off ...BuyM8.66143,4491,242,268584,520441.1 K to 584.5 K (+32.52 %)
Dec 02 2020NBIXNEUROCRINE BIOSCIE ...ABERNETHY MATTChief Financial Off ...SellS94.661,645155,72111,49413.1 K to 11.5 K (-12.52 %)
Nov 16 2020NBIXNEUROCRINE BIOSCIE ...BENEVICH ERICChief Commercial Of ...SellS90.712,257204,72317,40519.7 K to 17.4 K (-11.48 %)
Nov 16 2020NBIXNEUROCRINE BIOSCIE ...ROBERTS EIRYChief Medical Offic ...SellS90.742,257204,81013,47715.7 K to 13.5 K (-14.34 %)
Nov 16 2020NBIXNEUROCRINE BIOSCIE ...Lloyd-Smith MalcolmChief Regulatory Of ...SellS90.732,257204,77629,00231.3 K to 29 K (-7.22 %)
Nov 16 2020NBIXNEUROCRINE BIOSCIE ...Lippoldt DarinChief Legal OfficerSellS90.722,257204,75530,08232.3 K to 30.1 K (-6.98 %)
Nov 16 2020NBIXNEUROCRINE BIOSCIE ...Grigoriadis Dimitri E.Chief Research Offi ...SellS90.732,257204,78481,62483.9 K to 81.6 K (-2.69 %)
Nov 16 2020NBIXNEUROCRINE BIOSCIE ...GORMAN KEVIN CHARLESChief Executive Off ...SellS90.783,390307,748441,071444.5 K to 441.1 K (-0.76 %)
Nov 16 2020NBIXNEUROCRINE BIOSCIE ...Gano KyleChief Business Deve ...SellS90.732,257204,77098,028100.3 K to 98 K (-2.25 %)
Nov 16 2020NBIXNEUROCRINE BIOSCIE ...Cooke JulieChief Human Resourc ...SellS90.732,257204,77811,58013.8 K to 11.6 K (-16.31 %)
Nov 16 2020NBIXNEUROCRINE BIOSCIE ...Bozigian Haig P.Chief Development O ...SellS90.742,257204,806152,694155 K to 152.7 K (-1.46 %)
Nov 16 2020NBIXNEUROCRINE BIOSCIE ...ABERNETHY MATTChief Financial Off ...SellS90.742,257204,81010,01412.3 K to 10 K (-18.39 %)
Nov 04 2020NBIXNEUROCRINE BIOSCIE ...BENEVICH ERICChief Commercial Of ...Option ExerciseM35.9920,595741,2147,775
Nov 04 2020NBIXNEUROCRINE BIOSCIE ...BENEVICH ERICChief Commercial Of ...SellS96.5320,5951,987,97215,37436 K to 15.4 K (-57.26 %)
Nov 04 2020NBIXNEUROCRINE BIOSCIE ...BENEVICH ERICChief Commercial Of ...BuyM35.9920,595741,21435,96915.4 K to 36 K (+133.96 %)
Oct 06 2020NBIXNEUROCRINE BIOSCIE ...Cooke JulieChief Human Resourc ...SellS95.2698794,0229,54910.5 K to 9.5 K (-9.37 %)
Aug 07 2020NBIXNEUROCRINE BIOSCIE ...ROBERTS EIRYChief Medical Offic ...SellS118.842,257268,22511,44613.7 K to 11.4 K (-16.47 %)
Aug 07 2020NBIXNEUROCRINE BIOSCIE ...Lloyd-Smith MalcolmChief Regulatory Of ...SellS118.872,257268,27726,97129.2 K to 27 K (-7.72 %)
Aug 07 2020NBIXNEUROCRINE BIOSCIE ...Lippoldt DarinChief Legal OfficerSellS118.872,257268,29728,05130.3 K to 28.1 K (-7.45 %)
Aug 07 2020NBIXNEUROCRINE BIOSCIE ...Grigoriadis Dimitri E.Chief Research Offi ...SellS118.832,257268,20079,59381.9 K to 79.6 K (-2.76 %)
Aug 07 2020NBIXNEUROCRINE BIOSCIE ...GORMAN KEVIN CHARLESChief Executive Off ...SellS118.913,390403,101438,021441.4 K to 438 K (-0.77 %)
Aug 07 2020NBIXNEUROCRINE BIOSCIE ...Gano KyleChief Business Deve ...SellS118.872,257268,28695,99798.3 K to 96 K (-2.30 %)
Aug 07 2020NBIXNEUROCRINE BIOSCIE ...Cooke JulieChief Human Resourc ...SellS118.912,257268,3838,66110.9 K to 8.7 K (-20.67 %)
Aug 07 2020NBIXNEUROCRINE BIOSCIE ...Bozigian Haig P.Chief Development O ...SellS118.892,257268,324150,663152.9 K to 150.7 K (-1.48 %)
Aug 07 2020NBIXNEUROCRINE BIOSCIE ...BENEVICH ERICChief Commercial Of ...SellS118.852,257268,25415,37417.6 K to 15.4 K (-12.80 %)
Aug 07 2020NBIXNEUROCRINE BIOSCIE ...ABERNETHY MATTChief Financial Off ...SellS118.902,257268,3567,98310.2 K to 8 K (-22.04 %)
Jul 10 2020NBIXNEUROCRINE BIOSCIE ...Lippoldt DarinChief Legal OfficerOption ExerciseM35.991,65759,63536,194
Jul 10 2020NBIXNEUROCRINE BIOSCIE ...Lippoldt DarinChief Legal OfficerSellS136.021,657225,38626,02127.7 K to 26 K (-5.99 %)
Jul 10 2020NBIXNEUROCRINE BIOSCIE ...Lippoldt DarinChief Legal OfficerBuyM35.991,65759,63527,67826 K to 27.7 K (+6.37 %)
Jun 25 2020NBIXNEUROCRINE BIOSCIE ...ROBERTS EIRYChief Medical Offic ...Option ExerciseM77.815,000389,05059,860
Jun 25 2020NBIXNEUROCRINE BIOSCIE ...ROBERTS EIRYChief Medical Offic ...SellS130.005,000650,0009,41614.4 K to 9.4 K (-34.68 %)
Jun 25 2020NBIXNEUROCRINE BIOSCIE ...ROBERTS EIRYChief Medical Offic ...BuyM77.815,000389,05014,4169.4 K to 14.4 K (+53.10 %)
Jun 25 2020NBIXNEUROCRINE BIOSCIE ...Lippoldt DarinChief Legal OfficerOption ExerciseM32.995,000164,9500
Jun 25 2020NBIXNEUROCRINE BIOSCIE ...Lippoldt DarinChief Legal OfficerSellS130.005,000650,00026,02131 K to 26 K (-16.12 %)
Jun 25 2020NBIXNEUROCRINE BIOSCIE ...Lippoldt DarinChief Legal OfficerBuyM32.995,000164,95031,02126 K to 31 K (+19.22 %)
Jun 15 2020NBIXNEUROCRINE BIOSCIE ...Grigoriadis Dimitri E.Chief Research Offi ...Option ExerciseM43.241,04945,3592,151
Jun 15 2020NBIXNEUROCRINE BIOSCIE ...Grigoriadis Dimitri E.Chief Research Offi ...Option ExerciseM35.991,81265,2140
Jun 15 2020NBIXNEUROCRINE BIOSCIE ...Grigoriadis Dimitri E.Chief Research Offi ...Option ExerciseM32.992,71089,4030
Jun 15 2020NBIXNEUROCRINE BIOSCIE ...Grigoriadis Dimitri E.Chief Research Offi ...BuyM43.241,04945,35977,56376.5 K to 77.6 K (+1.37 %)
Jun 15 2020NBIXNEUROCRINE BIOSCIE ...Grigoriadis Dimitri E.Chief Research Offi ...BuyM35.991,81265,21476,51474.7 K to 76.5 K (+2.43 %)
Jun 15 2020NBIXNEUROCRINE BIOSCIE ...Grigoriadis Dimitri E.Chief Research Offi ...BuyM32.992,71089,40374,70272 K to 74.7 K (+3.76 %)
May 21 2020NBIXNEUROCRINE BIOSCIE ...SHERWIN STEPHEN ADirectorOption ExerciseA119.936,018721,7396,018
May 21 2020NBIXNEUROCRINE BIOSCIE ...POPS RICHARD FDirectorOption ExerciseA119.936,018721,7396,018
May 21 2020NBIXNEUROCRINE BIOSCIE ...Norwalk Leslie VDirectorOption ExerciseA119.936,018721,7396,018
May 21 2020NBIXNEUROCRINE BIOSCIE ...MORROW GEORGE JDirectorOption ExerciseA119.936,018721,7396,018
May 21 2020NBIXNEUROCRINE BIOSCIE ...LYONS GARY ADirectorOption ExerciseA119.936,018721,7396,018
May 21 2020NBIXNEUROCRINE BIOSCIE ...RASTETTER WILLIAM HDirectorOption ExerciseA119.936,018721,7396,018
May 20 2020NBIXNEUROCRINE BIOSCIE ...Lippoldt DarinChief Legal OfficerOption ExerciseM32.995,000164,9505,000
May 20 2020NBIXNEUROCRINE BIOSCIE ...Lippoldt DarinChief Legal OfficerSellS120.005,000600,00026,02131 K to 26 K (-16.12 %)
May 20 2020NBIXNEUROCRINE BIOSCIE ...Lippoldt DarinChief Legal OfficerBuyM32.995,000164,95031,02126 K to 31 K (+19.22 %)

Page:   1 2 3 4 5 ... 13 next >

Contact us | Follow us on Twitter